Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Mattia Longoni

Ospedale San Raffaele

Italy

Research Interests

Explore related searches

Professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (5)

ANTONIO GALFANO

Chief of Endourology Sub-unit

Niuvanniemi Hospital

ITALY

View details

Paolo Dell'Oglio

Urologist (Staff Member)

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

ITALY

View details

Giuseppe Simone

Chief

ITALY

View details

Marcin Miszczyk

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Fabio Zattoni

Prof

University of Padova

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mattia Longoni

Research Interests

Explore related searches

Articles (20)

ASO Author Reflections: Quantifying the Unseen: Years of Life Lost as a Patient-Centered Metric in Advanced Bladder Cancer

Re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019

Years of Life Lost in Patients with Muscle-Invasive and Metastatic Bladder Cancer

Real-world Adherence to European Association of Urology–recommended Non–muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes

Clinical and surgical management of recto-urinary fistula after radical prostatectomy: a systematic review on current evidence

ASO Visual Abstract: The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility Criteria

The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility Criteria

Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series

Response to Hof et al.: spurious associations between BCG instillations and outcomes in non‐muscle‐invasive bladder cancer

Comparative Assessment of Chemotherapy Followed by Consolidative Radical Cystectomy Versus Chemoradiation for Clinically Node-Positive Urothelial Carcinoma of the Bladder

Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study

Decision regret after robot-assisted radical prostatectomy: A systematic review and meta-analysis

Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure

Long-term Functional Outcomes and Decision Regret after Robot-assisted Radical Prostatectomy: An Experienced Surgeon Series

Current practices and variability in dynamic sentinel node biopsy for penile cancer: A survey of European Referral Centers

Establishing the role of single‐stage preputial spiral graft urethroplasty for panurethral stricture

Robot-assisted vs. open radical cystectomy: octogenarians vs. non octogenarians

Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines

A Narrative Review of Treatment Options for Patients with Node-Positive Disease After Radical Prostatectomy: Current Evidence and Controversies

Collaborators (5)

ANTONIO GALFANO

Paolo Dell'Oglio

Giuseppe Simone

Marcin Miszczyk

Fabio Zattoni

Make your next move.